» Articles » PMID: 10747206

Neurotoxins Affecting Neuroexocytosis

Overview
Journal Physiol Rev
Specialty Physiology
Date 2000 Apr 4
PMID 10747206
Citations 403
Authors
Affiliations
Soon will be listed here.
Abstract

Nerve terminals are specific sites of action of a very large number of toxins produced by many different organisms. The mechanism of action of three groups of presynaptic neurotoxins that interfere directly with the process of neurotransmitter release is reviewed, whereas presynaptic neurotoxins acting on ion channels are not dealt with here. These neurotoxins can be grouped in three large families: 1) the clostridial neurotoxins that act inside nerves and block neurotransmitter release via their metalloproteolytic activity directed specifically on SNARE proteins; 2) the snake presynaptic neurotoxins with phospholipase A(2) activity, whose site of action is still undefined and which induce the release of acethylcholine followed by impairment of synaptic functions; and 3) the excitatory latrotoxin-like neurotoxins that induce a massive release of neurotransmitter at peripheral and central synapses. Their modes of binding, sites of action, and biochemical activities are discussed in relation to the symptoms of the diseases they cause. The use of these toxins in cell biology and neuroscience is considered as well as the therapeutic utilization of the botulinum neurotoxins in human diseases characterized by hyperfunction of cholinergic terminals.

Citing Articles

A novel single-domain antibody obtained from immune Bactrian camels against botulinum toxin type A using SPR-based screening method.

Hu N, Peng F, Jiang Z, Wang Z, Peng S, Xing C Heliyon. 2025; 11(4):e42616.

PMID: 40066047 PMC: 11891721. DOI: 10.1016/j.heliyon.2025.e42616.


An automated platform for simultaneous, longitudinal analysis of engineered neuromuscular tissues for applications in neurotoxin potency testing.

Fleming J, McCloskey M, Gray K, Nash D, Leung V, Michas C Curr Res Toxicol. 2025; 8:100218.

PMID: 39944108 PMC: 11815696. DOI: 10.1016/j.crtox.2025.100218.


Botulinum Toxin: A Comprehensive Review of Its Molecular Architecture and Mechanistic Action.

Kumar R, Singh B Int J Mol Sci. 2025; 26(2).

PMID: 39859491 PMC: 11766063. DOI: 10.3390/ijms26020777.


Expression of Recombinant Clostridial Neurotoxin by .

Gregg B, Gupta S, Tepp W, Pellett S Microorganisms. 2025; 12(12.

PMID: 39770813 PMC: 11678509. DOI: 10.3390/microorganisms12122611.


Stable Convergent Polyneuronal Innervation and Altered Synapse Elimination in Muscles from Patients with Blepharospasm Responding Poorly to Recurrent Botulinum Type-A Neurotoxin Injections.

Girard B, Couesnon A, Girard E, Molgo J Toxins (Basel). 2024; 16(12.

PMID: 39728764 PMC: 11728458. DOI: 10.3390/toxins16120506.